Sun Pharma's arm receives USFDA’s approval for ELEPSIA XR 1000mg, 1500mg

21 Dec 2018 Evaluate

Sun Pharmaceutical Industries’ wholly owned subsidiary has received approval from US Food and Drug Administration (USFDA) for the New Drug Application (NDA), for Elepsia XR 1000 mg (levetiracetam 1000 mg) and Elepsia XR 1500 mg (levetiracetam 1500 mg). This product was filed from SPIL’s Halol facility in the state of Gujarat.

The company’s wholly owned subsidiary had in-licensed ELEPSIA XR from Sun Pharma Advanced Research Company (SPARC) in July 2016.

Sun Pharmaceutical Industries (SPIL) is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×